Viridian Therapeutics

VRDN

NASDAQHealth Care

Income Statement

Total Revenue$302K

Gross Profit$302K

Operating Income$-299.04M

EBITDA$-267.18M

EBIT$-267.72M

Pre-tax Income$-360.59M

Net Income$-269.95M

Cash Equivalent$124.8M

Total Debt$20.47M

Book Value$622.75M

Book Value Per Share9.24

Return on Equity (ROE)-40.19%

Return on Assets (ROA)-36.36%

Return on Invested Capital (ROI)-39.00%

Net Profit Margin-89387.09%

Current Ratio15.43

Quick Ratio14.99

Long-Term Debt / Equity0.03